BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 27835693)

  • 1. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2014 May; 34(4):491-503. PubMed ID: 24659206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 27 and its regulatory molecules express differentially in SLE patients with distinct autoantibody profiles.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Mar; 164(1):25-32. PubMed ID: 25655337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
    Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
    Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
    Hanly JG; Su L; Farewell V; Fritzler MJ
    J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
    Verdelli A; Coi A; Marzano AV; Antiga E; Cozzani E; Quaglino P; La Placa M; Benucci M; De Simone C; Papini M; Parodi A; Bianchi F; Caproni M
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):742-752. PubMed ID: 29924416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare autoantibodies to cellular antigens in systemic lupus erythematosus.
    Fredi M; Cavazzana I; Quinzanini M; Taraborelli M; Cartella S; Tincani A; Franceschini F
    Lupus; 2014 Jun; 23(7):672-7. PubMed ID: 24557777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway.
    Wen Z; Xu L; Chen X; Xu W; Yin Z; Gao X; Xiong S
    J Immunol; 2013 Jun; 190(11):5411-22. PubMed ID: 23616573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
    Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
    Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
    Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.